Anticoagulation Bleeding Mortality and Pathology in Hospitalized Patients with COVID-19

Nadkarni, G., Lala, A., Bagiella, E., et al.. (2021). Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients with COVID-19. (Added 12/23/2020.) Journal of the American College of Cardiology. 76(16):1815-1826.
This study, of more than 4,000 patients in 5 New York City hospitals between March 1, 2020 and April 30, 2020, found a 50% reduced hazard of in-hospital mortality and 30% reduced hazard of intubation among those with therapeutic and prophylactic anticoagulation (AC) in comparison to those with no AC. Autopsies suggested that clinical estimates thromboembolic disease may be underestimated.
Rate: Favorite:
You must Login to add a comment
  • This item doesn't have any comments

Enter your email address to receive important announcements and updates through the ASPR TRACIE Listserv.